EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Moderate to high throughput in vitro binding kinetics for drug discovery

Rumin Zhang, Christopher M Barbieri, Margarita Garcia-Calvo, Robert W Myers, David McLaren, Michael Kavana

Frontiers in Bioscience · 2016 · 8 (2) · 278-297

DOI: 10.2741/s462 ↗

At a glance

Übersichtsarbeit in Frontiers in Bioscience, 2016. Written by Rumin Zhang and 5 co-authors. Institution: In vitro Pharmacology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey, rumin.zhang@merck.com. Cited 20 times so far (Crossref).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

This review provides a concise summary for state of the art, moderate to high throughput in vitro technologies being employed to study drug-target binding kinetics. These technologies cover a wide kinetic timescale spanning up to nine orders of magnitude from milliseconds to days. Automated stopped flow measures transient and (pre)steady state kinetics from milliseconds to seconds. For seconds to hours timescale kinetics we discuss surface plasmon resonance-based biosensor, global progress curve analysis for high throughput kinetic profiling of enzyme inhibitors and activators, and filtration plate-based radioligand or fluorescent binding assays for receptor binding kinetics. Jump dilution after pre-incubation is the preferred method for very slow kinetics lasting for days. The basic principles, best practices and simulated data for these technologies are described. Finally, the application of a universal label-free technology, liquid chromatography coupled tandem mass spectrometry (LC/MS/MS), is briefly reviewed. Select literature references are highlighted for in-depth understanding. A new reality is dawning wherein binding kinetics is an integral and routine part of mechanism of action elucidation and translational, quantitative pharmacology for drug discovery.

Subjects

MeSH terms (MEDLINE)

Biosensing TechniquesDrug DiscoveryEnzyme ActivatorsEnzyme InhibitorsHigh-Throughput Screening AssaysPharmacokineticsSurface Plasmon ResonanceTandem Mass Spectrometry

Substances

Enzyme ActivatorsEnzyme Inhibitors

Authors and institutions

  • In vitro Pharmacology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey, rumin.zhang@merck.com.
  • In vitro Pharmacology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey, USA.

Cite

APA

Zhang, R., Barbieri, C. M., Garcia-Calvo, M., Myers, R. W., McLaren, D., & Kavana, M. (2016). Moderate to high throughput in vitro binding kinetics for drug discovery. Frontiers in Bioscience, 8(2), 278-297. https://doi.org/10.2741/s462

Vancouver

Zhang R, Barbieri CM, Garcia-Calvo M, Myers RW, McLaren D, Kavana M. Moderate to high throughput in vitro binding kinetics for drug discovery. Frontiers in Bioscience. 2016;8(2):278-297. doi:10.2741/s462

BibTeX
@article{Zhang2016,
  author = {Zhang, Rumin and Barbieri, Christopher M and Garcia-Calvo, Margarita and Myers, Robert W and McLaren, David and Kavana, Michael},
  title = {Moderate to high throughput in vitro binding kinetics for drug discovery},
  journal = {Frontiers in Bioscience},
  year = {2016},
  volume = {8},
  number = {2},
  pages = {278--297},
  doi = {10.2741/s462}
}
Start for free →